Nifty

:

24894.25

Sensex

:

81207.17

57.95 (0.23%)
223.86 (0.28%)

Login

Nifty
Sensex

:
:

24894.25
81207.17

57.95 (0.23%)
223.86 (0.28%)

Entero Healthcare Solutions Ltd.

Trading

Rating :

69/99

BSE: 544122 | NSE: ENTERO

Watchlist

NSE BSE

1092.60

03-Oct-2025

Open
High
Low
Previous Close

1105
1105
1082.2
1097.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

160070
174444370.2
1584.25
1057.1

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,762.92
46.45
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,801.31
N/A
2.72

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
15.58

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
21.79

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Earnings Forecasts:

(Updated: 04-10-2025)

Description 2024 2025 2026 2027
Adj EPS 21.8 36.9 52.42 62.46
P/E Ratio 50.12 29.61 20.84 17.49
Revenue 5095.78 6576.23 8295.47 10292.5
EBITDA 171.55 259.16 362.9 484.4
Net Income 94.82 163.43 232.57 285.13
ROA 3.76 6 7.25 9.1
P/B Ratio 2.76 2.47 2.22 1.96
ROE 5.64 8.59 10.89 11.7
FCFF -91.64 -17.18 -94.67 -12.33
FCFF Yield -1.89 -0.35 -1.95 -0.25
Net Debt 67.25 73.35 167.93 199.53
BVPS 396.28 441.53 492.87 556.96

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 79.35 122.38 -35.16% 72.30 106.56 -32.15% 101.15 76.59 32.07% 112.83 73.81 52.87%
Expenses 93.06 124.23 -25.09% 84.24 115.75 -27.22% 111.63 85.08 31.21% 118.91 83.00 43.27%
EBITDA -13.71 -1.85 - -11.94 -9.19 - -10.48 -8.50 - -6.08 -9.19 -
EBIDTM -17.27% -1.51% -16.51% -8.62% -10.36% -11.10% -5.38% -12.45%
Other Income 26.29 32.17 -18.28% 25.87 42.39 -38.97% 27.51 16.25 69.29% 28.81 16.52 74.39%
Interest 0.59 0.41 43.90% 0.35 5.61 -93.76% 0.37 4.73 -92.18% 0.39 7.32 -94.67%
Depreciation 2.82 2.17 29.95% 2.16 1.73 24.86% 2.19 2.32 -5.60% 2.13 2.29 -6.99%
PBT 9.16 27.74 -66.98% -35.65 25.87 - 14.47 0.70 1,967.14% 20.22 -2.29 -
Tax 2.21 6.87 -67.83% -7.85 -11.41 - 3.69 -0.25 - 4.89 -0.14 -
PAT 6.96 20.88 -66.67% -27.81 37.28 - 10.78 0.95 1,034.74% 15.33 -2.14 -
PATM 8.77% 17.06% -38.46% 34.98% 10.66% 1.24% 13.59% -2.90%
EPS 1.60 4.80 -66.67% -6.39 8.57 - 2.48 0.22 1,027.27% 3.52 -0.49 -

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 1,403.82 1,097.04 27.96% 1,339.06 1,034.18 29.48% 1,359.00 992.63 36.91% 1,300.69 996.30 30.55%
Expenses 1,353.75 1,066.86 26.89% 1,290.14 1,005.30 28.33% 1,308.98 964.03 35.78% 1,258.24 967.73 30.02%
EBITDA 50.07 30.17 65.96% 48.91 28.88 69.36% 50.01 28.60 74.86% 42.45 28.57 48.58%
EBIDTM 3.57% 2.75% 3.65% 2.79% 3.68% 2.88% 3.26% 2.87%
Other Income 5.83 13.44 -56.62% 7.29 9.15 -20.33% 7.50 1.79 318.99% 11.28 2.08 442.31%
Interest 10.66 9.70 9.90% 10.49 17.32 -39.43% 9.97 16.07 -37.96% 11.46 17.90 -35.98%
Depreciation 8.87 6.61 34.19% 8.49 7.14 18.91% 8.10 5.99 35.23% 7.49 5.93 26.31%
PBT 36.36 27.30 33.19% 37.23 13.56 174.56% 39.44 8.32 374.04% 34.78 6.82 409.97%
Tax 6.13 6.77 -9.45% 5.80 -7.62 - 9.99 1.34 645.52% 8.74 1.60 446.25%
PAT 30.23 20.53 47.25% 31.42 21.18 48.35% 29.45 6.98 321.92% 26.03 5.21 399.62%
PATM 2.15% 1.87% 2.35% 2.05% 2.17% 0.70% 2.00% 0.52%
EPS 6.39 4.62 38.31% 5.90 4.82 22.41% 5.85 4.22 38.63% 5.43 3.19 70.22%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22
Net Sales 365.63 408.67 318.16 177.69 137.29 Net Sales Growth -3.61% 28.45% 79.05% 29.43% Cost Of Goods Sold 327.75 362.22 269.54 154.53 128.44 Gross Profit 37.88 46.45 48.62 23.16 8.85 GP Margin 10.36% 11.37% 15.28% 13.03% 6.45% Total Expenditure 407.84 439.02 352.65 221.61 191.00 Power & Fuel Cost - 0.89 0.87 0.66 0.57 % Of Sales - 0.22% 0.27% 0.37% 0.42% Employee Cost - 47.35 56.25 43.59 37.92 % Of Sales - 11.59% 17.68% 24.53% 27.62% Manufacturing Exp. - 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% General & Admin Exp. - 14.84 13.96 10.54 14.78 % Of Sales - 3.63% 4.39% 5.93% 10.77% Selling & Distn. Exp. - 10.52 8.57 10.37 8.72 % Of Sales - 2.57% 2.69% 5.84% 6.35% Miscellaneous Exp. - 3.19 3.46 1.90 0.58 % Of Sales - 0.78% 1.09% 1.07% 0.42% EBITDA -42.21 -30.35 -34.49 -43.92 -53.71 EBITDA Margin -11.54% -7.43% -10.84% -24.72% -39.12% Other Income 108.48 114.37 89.92 52.57 26.87 Interest 1.70 1.52 22.32 11.30 5.29 Depreciation 9.30 8.64 8.75 9.80 8.71 PBT 8.20 73.86 24.36 -12.46 -40.85 Tax 2.94 7.60 -14.07 0.00 0.00 Tax Rate 35.85% 28.38% -57.76% 0.00% 0.00% PAT 5.26 19.18 38.44 -12.46 -40.85 PAT before Minority Interest 5.26 19.18 38.44 -12.46 -40.85 Minority Interest 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.44% 4.69% 12.08% -7.01% -29.75% PAT Growth -90.77% -50.10% - - EPS 1.21 4.41 8.84 -2.86 -9.39

Description TTM Mar 25 Mar 24 Mar 23 Mar 22
Net Sales 5,402.57 5,095.78 3,922.31 3,300.21 2,522.07 Net Sales Growth 31.13% 29.92% 18.85% 30.85% Cost Of Goods Sold 4,876.66 4,609.47 3,570.36 3,031.87 2,312.44 Gross Profit 525.91 486.31 351.96 268.34 209.63 GP Margin 9.73% 9.54% 8.97% 8.13% 8.31% Total Expenditure 5,211.11 4,924.23 3,810.47 3,236.20 2,497.63 Power & Fuel Cost - 7.20 5.59 4.25 4.07 % Of Sales - 0.14% 0.14% 0.13% 0.16% Employee Cost - 199.04 151.15 128.14 114.81 % Of Sales - 3.91% 3.85% 3.88% 4.55% Manufacturing Exp. - 1.38 1.29 1.26 1.22 % Of Sales - 0.03% 0.03% 0.04% 0.05% General & Admin Exp. - 39.47 34.36 30.08 28.85 % Of Sales - 0.77% 0.88% 0.91% 1.14% Selling & Distn. Exp. - 52.39 36.28 29.68 26.01 % Of Sales - 1.03% 0.92% 0.90% 1.03% Miscellaneous Exp. - 15.27 11.44 10.93 10.23 % Of Sales - 0.30% 0.29% 0.33% 0.41% EBITDA 191.44 171.55 111.84 64.01 24.44 EBITDA Margin 3.54% 3.37% 2.85% 1.94% 0.97% Other Income 31.90 39.51 14.41 5.51 4.48 Interest 42.58 41.62 65.68 48.97 28.98 Depreciation 32.95 30.69 25.02 24.24 19.75 PBT 147.81 138.74 35.55 -3.69 -19.81 Tax 30.66 31.30 -4.24 7.42 9.63 Tax Rate 20.74% 22.56% -11.93% -201.08% -48.61% PAT 117.13 94.82 39.11 -11.55 -29.92 PAT before Minority Interest 102.53 107.43 39.80 -11.10 -29.44 Minority Interest -14.60 -12.61 -0.69 -0.45 -0.48 PAT Margin 2.17% 1.86% 1.00% -0.35% -1.19% PAT Growth 117.31% 142.44% - - EPS 26.93 21.80 8.99 -2.66 -6.88

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,650.38 1,626.41 583.73 551.21 Share Capital 43.51 43.49 667.73 622.84 Total Reserves 1,602.64 1,581.15 -83.99 -71.64 Non-Current Liabilities 16.82 0.31 45.23 22.92 Secured Loans 0.00 0.00 28.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 Long Term Provisions 3.23 1.40 1.04 0.75 Current Liabilities 129.93 127.82 134.60 79.96 Trade Payables 86.05 64.90 55.75 34.75 Other Current Liabilities 43.01 61.28 14.02 12.17 Short Term Borrowings 0.00 0.00 63.50 30.00 Short Term Provisions 0.87 1.65 1.34 3.04 Total Liabilities 1,797.13 1,754.54 763.56 654.09 Net Block 28.29 34.44 40.65 51.42 Gross Block 73.40 72.11 69.63 72.17 Accumulated Depreciation 45.11 37.67 28.98 20.75 Non Current Assets 987.67 93.56 90.56 96.81 Capital Work in Progress 0.26 0.00 0.00 0.05 Non Current Investment 251.62 40.54 40.64 39.43 Long Term Loans & Adv. 701.84 13.51 7.87 5.91 Other Non Current Assets 5.66 5.06 1.40 0.00 Current Assets 809.46 1,660.98 673.00 557.27 Current Investments 25.76 0.00 0.00 0.00 Inventories 108.98 47.81 28.84 36.23 Sundry Debtors 99.86 113.19 74.48 52.23 Cash & Bank 170.06 792.35 77.19 88.24 Other Current Assets 404.81 97.08 56.68 38.89 Short Term Loans & Adv. 255.02 610.56 435.82 341.68 Net Current Assets 679.53 1,533.16 538.40 477.31 Total Assets 1,797.13 1,754.54 763.56 654.08

Description Mar 25 Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,724.14 1,638.06 595.03 561.04 Share Capital 43.51 43.49 667.73 622.84 Total Reserves 1,676.40 1,592.79 -72.70 -61.80 Non-Current Liabilities 72.84 82.62 85.10 100.31 Secured Loans 0.00 45.54 31.07 37.13 Unsecured Loans 0.00 0.00 0.00 0.00 Long Term Provisions 9.64 7.11 5.40 4.43 Current Liabilities 845.02 601.95 623.96 461.78 Trade Payables 397.30 229.91 210.50 139.78 Other Current Liabilities 137.88 135.04 67.11 64.91 Short Term Borrowings 298.81 230.01 342.45 247.90 Short Term Provisions 11.02 6.98 3.90 9.19 Total Liabilities 2,688.21 2,325.96 1,306.72 1,125.30 Net Block 559.28 289.34 267.73 261.97 Gross Block 686.47 383.26 338.72 311.22 Accumulated Depreciation 127.19 93.93 70.99 49.25 Non Current Assets 612.50 314.97 283.55 274.42 Capital Work in Progress 0.26 0.00 0.00 0.64 Non Current Investment 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 47.16 20.20 14.42 11.81 Other Non Current Assets 5.80 5.44 1.40 0.00 Current Assets 2,075.71 2,010.97 1,023.17 850.88 Current Investments 57.55 0.00 0.00 0.00 Inventories 659.78 421.15 341.63 310.16 Sundry Debtors 830.36 615.40 514.88 374.60 Cash & Bank 260.42 893.18 106.84 105.40 Other Current Assets 267.60 40.52 23.17 24.35 Short Term Loans & Adv. 201.31 40.71 36.65 36.38 Net Current Assets 1,230.69 1,409.03 399.21 389.10 Total Assets 2,688.21 2,325.94 1,306.72 1,125.30

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22
Cash From Operating Activity -109.02 -75.65 -56.91 -44.70 PBT 26.78 24.36 -12.46 -40.85 Adjustment -44.83 -38.43 -29.51 -9.38 Changes in Working Capital -74.31 -59.79 -12.41 6.49 Cash after chg. in Working capital -92.36 -73.86 -54.38 -43.74 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -16.65 -1.79 -2.53 -0.96 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity 207.74 -762.69 -58.29 -68.80 Net Fixed Assets -1.55 -2.48 2.59 Net Investments -236.84 0.10 -1.21 Others 446.13 -760.31 -59.67 Cash from Financing Activity -40.89 925.56 91.11 127.48 Net Cash Inflow / Outflow 57.84 87.22 -24.09 13.98 Opening Cash & Equivalents 93.34 6.12 30.20 16.22 Closing Cash & Equivalent 151.18 93.34 6.12 30.20

Description Mar 25 Mar 24 Mar 23 Mar 22
Cash From Operating Activity -76.87 -36.61 -45.31 -35.27 PBT 138.74 35.55 -3.69 -19.81 Adjustment 44.05 86.62 71.16 41.52 Changes in Working Capital -221.52 -145.73 -100.36 -46.07 Cash after chg. in Working capital -38.73 -23.55 -32.89 -24.36 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -38.14 -13.06 -12.43 -10.90 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity 219.80 -705.12 -48.59 -161.73 Net Fixed Assets -1.55 -2.48 2.59 Net Investments -236.84 0.10 -1.21 Others 458.19 -702.74 -49.97 Cash from Financing Activity -73.66 862.94 72.76 211.19 Net Cash Inflow / Outflow 69.27 121.21 -21.15 14.19 Opening Cash & Equivalents 147.65 25.36 46.51 32.31 Closing Cash & Equivalent 229.28 147.65 25.36 46.51

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22
Book Value (Rs.) 378.35 373.53 -194.27 -176.06 ROA 1.08% 3.05% -1.76% -6.88% ROE 1.17% 4.98% 0.00% 0.00% ROCE 1.73% 4.06% -0.18% -6.66% Fixed Asset Turnover 5.62 4.49 2.51 2.04 Receivable days 95.14 107.65 130.14 110.45 Inventory Days 70.01 43.97 66.83 111.15 Payable days 76.05 81.69 106.88 67.76 Cash Conversion Cycle 89.10 69.92 90.10 153.84 Total Debt/Equity 0.00 0.00 0.16 0.05 Interest Cover 18.66 2.09 -0.10 -6.72

Description Mar 25 Mar 24 Mar 23 Mar 22
Book Value (Rs.) 395.31 376.21 -166.80 -150.52 ROA 4.29% 2.19% -0.91% -3.01% ROE 6.40% 5.08% 0.00% 0.00% ROCE 9.16% 7.02% 4.99% 1.24% Fixed Asset Turnover 9.53 10.87 10.16 9.53 Receivable days 51.78 52.59 49.19 44.63 Inventory Days 38.71 35.49 36.04 40.09 Payable days 24.83 22.51 21.08 18.67 Cash Conversion Cycle 65.66 65.57 64.15 66.06 Total Debt/Equity 0.17 0.17 0.63 0.51 Interest Cover 4.33 1.54 0.92 0.32

Top Investors:

surbhi singh(prasid uno family trust)

invesco india aggressive hybrid fund

smallcap world fund, inc

government of singapore

stichting depositary apg emerging markets equity pool

Annual Reports:

News Update:

Entero Healthcare Solutions gets nod to sell entire stake in Suprabhat
29th Sep 2025, 16:15 PM

The Board has also approved, inter-alia, to execute Share Purchase Agreement, for acquiring 60% stake in Ace Cardiopathy Solutions
Read More
Entero Healthcare - Quarterly Results
8th Aug 2025, 17:47 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback